Viewing accessible and affordable health care as a universal right, for 20 years ICCR members have been advocating for the equitable access and affordability of life-saving medicines in emerging markets where poor public health exerts downward pressure on growth. From pandemic diseases, to neglected tropical diseases (NTDs) and non-communicable diseases (NCDs), ICCR members engage leading pharmaceutical companies in an effort to reduce the disease burden borne by these communities and to promote value-creating behavior and innovative health programs to help resolve some of the world's most intractable diseases.
Featured ICCR Initiative
Pediatric HIV/AIDS formulations. Of the 3.4 million children living with HIV, only 562,000 currently have access to the medicines they need.
The Access to Medicines Index: The Access to Medicine Index ranks pharmaceutical companies’ efforts to improve access to medicine in developing countries.
The Medicines Patent Pool: The MPP aims to lower the prices of HIV medicines and facilitate the development of better-adapted HIV medicines in developing countries. See more: